Pricing Log in Create free account
Saturday 17 October 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cencora, Inc. (COR) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Cencora, Inc. (COR) trades at a P/E ratio of 25.2×. Over the past ten years it has ranged from 0.0× (September 2021) to 1,035× (March 2015); the current reading is higher than 76% of that period. That is above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 39.0× 31.24%
FY2024 29.7× 42.77%
FY2023 20.8× 25.11%
FY2022 16.6× 4.11%
FY2021 16.0× —
FY2020 0.0× —
FY2019 20.2× 65.68%
FY2018 12.2× (72.15%)
FY2017 43.8× 268.52%
FY2016 11.9× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 20.9× (12.58%)
Mar 2026 23.9× (40.59%)
Dec 2025 40.3× 3.43%
Sep 2025 39.0× 27.23%
42 more quarters

Against its own ten years

Low 0.0× High 1,035×
Ten-year median 19.4×
Current reading's percentile 73

P/E ratio against peers

Company P/E ratio
ACH Accendra Health, Inc. compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
COSM Cosmos Health Inc. compare n/m
HSIC Henry Schein, Inc. compare 25.0×
COR Cencora, Inc. 25.2×
MCK McKesson Corporation compare 26.8×
CAH Cardinal Health, Inc. compare 35.0×
HKPD Cellyan Biotechnology Co., Ltd compare —
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on COR